我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
0
0 进行中
药物批准
1
批准总数
监管机构
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
HSA
Health Sciences Authority
<p><strong>4.1 Inhixa is indicated in adults for:</strong><br> Prophylaxis of venous thromboembolic disease (prevention of blood clot formation in the veins), in particular those which may be associated with orthopedic or general surgery.</p> <p>Prophylaxis of venous thromboembolic disease in medical patients bedridden due to acute illnesses.</p> <p>Treatment of established deep vein thrombosis.</p> <p>Prevention of thrombus formation in extracorporeal circulation during haemodialysis.</p> <p>Treatment of unstable angina and non-Q-wave myocardial infarction, administered concurrently with aspirin.</p> <p>Treatment of acute ST-segment Elevation Myocardial Infarction (STEMI), in combination with a thrombolytic agent, in patients to be managed medically or with subsequent Percutaneous Coronary Intervention (PCI).</p>
暂无资讯文章